SYK Stryker Corp
Stryker Corp. engages in providing medical technology products and services. It operates through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine. The Orthopaedics segment provides reconstructive and trauma implant systems. The Medsurg segment deals with surgical equipment and navigation systems, endoscopy, patient handling, and reprocessed medical devices. The Neurotechnology and Spine segment pertains to spinal implants and neurovascular products. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
Company profile
Ticker
SYK
Exchange
CEO
Kevin A. Lobo
Employees
Incorporated in
Location
Fiscal year end
Sector
Industry (SEC)
3M • Baxter International • ResMed • Integra Lifesciences • Hill-Rom • Haemonetics • NuVasive • AngioDynamics • Merit Medical Systems • Globus Medical ...
SEC CIK
Corporate docs
IRS number
381239739
SYK stock data
()
Calendar
26 Jul 19
22 Aug 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | 3.65B | 3.52B | 3.8B | 3.24B | |
| Net income | 480M | 412M | 2.07B | 590M | |
| Diluted EPS | 1.26 | 1.09 | 5.44 | 1.55 | |
| Net profit margin | 13.15% | 11.72% | 54.48% | 18.20% | |
| Operating income | 613M | 528M | 698M | 576M | |
| Net change in cash | 80M | -1.94B | 1.7B | 277M | |
| Cash on hand | 1.75B | 1.67B | 3.62B | 1.92B | |
| Cost of revenue | 1.27B | 1.23B | 1.34B | 1.09B |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 13.6B | 12.44B | 11.33B | 9.95B | |
| Net income | 3.55B | 1.02B | 1.65B | 1.44B | |
| Diluted EPS | 9.34 | 2.68 | 4.35 | 3.78 | |
| Net profit margin | 26.12% | 8.20% | 14.54% | 14.47% | |
| Operating income | 2.54B | 2.3B | 2.18B | 1.86B | |
| Net change in cash | 1.07B | -774M | -63M | 1.58B | |
| Cash on hand | 3.62B | 2.54B | 3.32B | 3.38B | |
| Cost of revenue | 4.66B | 4.26B | 3.82B | 3.34B |
Financial data from Stryker earnings reports
Financial report summary
?Competition
Fuse Medical • Span America Medical Systems • AxoGen • Kinetic Concepts • Merit Medical Systems • Misonix • Orthofix Medical • Integra Lifesciences • Djo • Surgline International
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
8th grade Good
|
|
New words:
audit, billion, charter, denominated, functional, spot
Financial reports
10-Q
2019 Q2
Quarterly report
26 Jul 19
10-Q
2019 Q1
Quarterly report
24 Apr 19
10-K
2018 FY
Annual report
7 Feb 19
10-Q
2018 Q3
Quarterly report
26 Oct 18
10-Q
2018 Q2
Quarterly report
25 Jul 18
10-Q
2018 Q1
Quarterly report
27 Apr 18
10-K
2017 FY
Annual report
8 Feb 18
10-Q
2017 Q3
Quarterly report
27 Oct 17
10-Q
2017 Q2
Quarterly report
28 Jul 17
10-Q
2017 Q1
Quarterly report
27 Apr 17
Current reports
8-K
Amendments to Articles of Incorporation or Bylaws
6 Aug 19
8-K
Stryker Reports Second Quarter 2019 Operating Results
25 Jul 19
8-K
Submission of Matters to a Vote of Security Holders
7 May 19
8-K
Stryker Reports First Quarter 2019 Operating Results
23 Apr 19
8-K
Departure of Directors or Certain Officers
27 Mar 19
8-K
Stryker Reports 2018 Results and 2019 Outlook
29 Jan 19
8-K
Entry into a Material Definitive Agreement
30 Nov 18
8-K
Stryker completes acquisition of K2M
9 Nov 18
8-K
Stryker Reports Third Quarter 2018 Operating Results
25 Oct 18
8-K
Stryker announces definitive agreement to acquire K2M
30 Aug 18
Registration and prospectus
S-3ASR
Automatic shelf registration
7 Feb 19
8-A12B
Registration of securities on exchange
30 Nov 18
424B5
Prospectus supplement for primary offering
29 Nov 18
FWP
Free writing prospectus
27 Nov 18
424B5
Prospectus supplement for primary offering
27 Nov 18
SC TO-T/A
Third party tender offer statement (amended)
23 Oct 18
SC TO-T/A
Third party tender offer statement (amended)
11 Oct 18
SC TO-T/A
Third party tender offer statement (amended)
1 Oct 18
SC TO-T
Third party tender offer statement
24 Sep 18
SC TO-C
Information about tender offer
11 Sep 18
Proxies
DEFA14A
Additional proxy soliciting materials
20 Mar 19
DEF 14A
Definitive proxy
20 Mar 19
DEF 14A
Definitive proxy
21 Mar 18
DEFA14A
Additional proxy soliciting materials
21 Mar 18
DEF 14A
Definitive proxy
20 Mar 17
DEFA14A
Additional proxy soliciting materials
20 Mar 17
DEFA14A
Additional proxy soliciting materials
16 Mar 16
DEF 14A
Definitive proxy
16 Mar 16
DEFA14A
Additional proxy soliciting materials
30 Mar 15
DEF 14A
Definitive proxy
19 Mar 15
Other
SD
Conflict minerals disclosure
31 May 19
SD
Conflict minerals disclosure
31 May 18
SD
Conflict minerals disclosure
31 May 17
SD
Conflict minerals disclosure
31 May 16
SD
Conflict minerals disclosure
1 Jun 15
SD
Conflict minerals disclosure
2 Jun 14
UPLOAD
Letter from SEC
13 Dec 13
CORRESP
Correspondence with SEC
3 Dec 13
UPLOAD
Letter from SEC
19 Nov 13
UPLOAD
Letter from SEC
26 Apr 12